| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |